Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4671665 | 0.84 | ESR1 (0.38) | FDPSALDH1A1 | |
| SCHEMBL31680348 | 0.82 | FDPS (0.39) | FDPSALDH1A1 | |
| SCHEMBL3458842 | 0.74 | FDPS (0.41) | FDPSALDH1A1 | |
| SCHEMBL4625451 | 0.72 | FDPS (0.36) | FDPSALDH1A1 | |
| SCHEMBL18421819 | 0.72 | ESR1 (0.34) | FDPS | |
| SCHEMBL28985873 | 0.71 | ALDH1A1 (0.41) | FDPSALDH1A1 | |
| Hydrogen Peroxide SCHEMBL28379737 | 0.71 | — | — | |
| SCHEMBL4669445 | 0.71 | — | — | |
| SCHEMBL28926749 | 0.71 | FDPS (0.39) | FDPSALDH1A1 | |
| SCHEMBL8777958 | 0.71 | FDPS (0.39) | FDPSALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218254-A1 | ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME | MIYOSHI OIL & FAT CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240057587-A1 | ORGANIC AMMONIUM SALT AND HYDROGEN-BONDING MATERIAL TREATMENT AGENT USING SAME | MIYOSHI OIL & FAT CO.,LTD. (JP) | 2024-02-22 | — | — | US | disclosed |
| EP-3766969-B1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | MIYOSHI YUSHI KK (JP) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022181381-A1 | ORGANIC AMMONIUM SALT HAVING PHOSPHONATE OR PHOSPHINATE ANION, AND COMPOSITION WHICH IS CAPABLE OF FORMING SAID SALT | ミヨシ油脂株式会社 | 2022-09-01 | — | — | WO | disclosed |
| EP-3766969-A1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | Miyoshi Oil & Fat Co., Ltd. (JP) | 2021-01-20 | — | — | EP | disclosed |
| EP-3130670-B1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | MIYOSHI YUSHI KK (JP) | 2020-10-21 | — | — | EP | disclosed |
| WO-2020166678-A1 | COSMETIC INGREDIENT, COSMETIC, AND PRODUCTION METHOD FOR COSMETIC | ミヨシ油脂株式会社 | 2020-08-20 | — | — | WO | disclosed |
| WO-2020166674-A1 | COMPOSITION CONTAINING ORGANIC AMMONIUM SALT | ミヨシ油脂株式会社 | 2020-08-20 | — | — | WO | disclosed |
| US-10240141-B2 | Biocatalyst solvent using ionic liquid, and biocatalyst solution containing biocatalyst and said solvent | MIYOSHI OIL & FAT CO., LTD. (JP) | 2019-03-26 | — | — | US | disclosed |
| EP-3130670-A1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | Miyoshi Oil & Fat Co., Ltd. (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-20170029801-A1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | MIYOSHI OIL & FAT CO., LTD. (JP) | 2017-02-02 | — | — | US | disclosed |
| EP-1585530-A4 | BIOADHESIVE PHARMACEUTICAL COMPOSITIONS | BARBEAU DONALD L (US) | 2009-09-09 | — | — | EP | disclosed |
| US-7119079-B2 | Bioadhesive pharmaceutical compositions | B&G PARTNERS LLC | 2006-10-10 | — | — | US | disclosed |
| EP-1585530-A2 | BIOADHESIVE PHARMACEUTICAL COMPOSITIONS | Barbeau, Donald L. (US) | 2005-10-19 | — | — | EP | disclosed |
| WO-2004064754-A2 | BIOADHESIVE PHARMACEUTICAL COMPOSITIONS | BARBEAU DONALD L (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20040142880-A1 | Bioadhesive pharmaceutical compositions | B&G PARTNERS LLC | 2004-07-22 | — | — | US | disclosed |
| US-6699848-B1 | USEFUL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | B&G PARTNERS LLC | 2004-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10240141-B2 | Biocatalyst solvent using ionic liquid, and biocatalyst solution containing biocatalyst and said solvent | BCKDK, HACL2, HAO2 | FDPS 4711/4885ALDH1A1 68/4885 |
| US-20040142880-A1 | Bioadhesive pharmaceutical compositions | UGT1A10, APOL1, ALG1 | FDPS 4197/4885ALDH1A1 628/4885 |
| US-20240057587-A1 | ORGANIC AMMONIUM SALT AND HYDROGEN-BONDING MATERIAL TREATMENT AGENT USING SAME | OR10J3, HCN4, CLIC4 | FDPS 4853/4885ALDH1A1 2015/4885 |
| US-20240218254-A1 | ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME | HAO2, NOTUM, FFAR2 | FDPS 3936/4885ALDH1A1 918/4885 |
| US-20170029801-A1 | BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT | BCKDK, HACL2, HAO2 | FDPS 4711/4885ALDH1A1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.